Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)

OBJECTIVE: Osteopontin (OPN) is an extracellular matrix protein that plays an integral role in myocardial remodelling and has previously been shown to be a valuable biomarker in cardiovascular disease. Because of the concentric myocardial hypertrophy associated with severe, symptomatic aortic stenos...

Descripción completa

Detalles Bibliográficos
Autores principales: Lutz, Matthias, von Ingersleben, Nora, Lambers, Moritz, Rosenberg, Mark, Freitag-Wolf, Sandra, Dempfle, Astrid, Lutter, Georg, Frank, Johanne, Bramlage, Peter, Frey, Norbert, Frank, Derk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Valvular Heart Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515168/
https://www.ncbi.nlm.nih.gov/pubmed/28761684
http://dx.doi.org/10.1136/openhrt-2017-000633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515168/
https://www.ncbi.nlm.nih.gov/pubmed/28761684
http://dx.doi.org/10.1136/openhrt-2017-000633

Ejemplares similares